Bristol-Myers Squibb names CEO to chairman post

Workflow Solutions
Products
See more S&P Global Solutions
See More IHS Markit Solutions
Content
How We Can Help
See More
News & Insights Topics
See More
Featured Events
In PersonPolitics & Policy: Market Impacts and Mid-Year Outlooks
- 06/24/2022
- Sofitel Washington DC Lafayette Square
- 8:30 AM – 12:00 PM ET
Webinar ReplaysExpand Your Perspective: Analyzing Deal Activity & Drivers Across the Capital Markets
- 06/08/2022
- On-Demand
- 1 Hour
In Person451Nexus
- 10/03/2022
- ARIA Resort and Casino, Las Vegas, Nevada
- ARIA Resort and Casino
Platforms
Other Products
- Leveraged Commentary and Data
- Research Online

In This List

Blog

Commercial Banking: June 22nd Edition

Blog

Understanding Loss Given Default A Review of Three Approaches

Blog

Commercial Banking Newsletter June Edition - 2022

Blog

Insight Weekly: US recession outlook; mortgage activity slowdown; climate disclosure push

21 Dec, 2016 | 14:54

Author Tayyeba Irum
Theme Healthcare & Pharmaceuticals

Bristol-Myers Squibb Co.'s board appointed CEO Giovanni Caforio as chairman, effective May 2, 2017.

Caforio will retain his position as CEO. He succeeds current Chairman Lamberto Andreotti, who plans to retire.

Andreotti will have served as chairman for two years when Caforio's appointment becomes effective. Caforio has been CEO since May 2015 and has been serving on the board since June 2014.